Domov › Rakovina prsníka › New Hampshire
Klinické štúdie Rakovina prsníka v štáte New Hampshire
16 štúdií pre Rakovina prsníka hľadá účastníkov v zariadeniach v štáte New Hampshire.
Oficiálny text štúdie (anglicky)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- New Hampshire Oncology Hematology PA-Concord, Concord
- Solinsky Center for Cancer Care, Manchester
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 40 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05334069The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Dana-Farber/New Hampshire Oncology-Hematology, Londonderry
Prebieha náborFáza 3
Vek 60 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06377852Testing a Mammography Decision Intervention in a Rural Setting
- Cheshire Medical Center, Keene
- New London Hospital Primary Care, New London
- Newport Health Center, Newport
Prebieha nábor
Vek 39 až 49 · Ženy · Aktualizované 24. 9. 2026 · NCT06522568Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Lebanon
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT07085767A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Dartmouth-Hitchcock Medical Center, Lebanon
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07174336A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Dartmouth Hitchcock Medical, Lebanon
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT06253871Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Dartmouth Hitchcock Medical Center, Lebanon
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT06072612Pilot SMART of a Remotely Delivered, Physical Activity Intervention for Breast Cancer Survivors
- Dartmouth-Hitchcock Clinic, Lebanon
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07706556ATEMPT 2.0: Adjuvant T-DM1 vs TH
- NH Oncology-Hematology, PA - Payson Center for Cancer Care, Concord
- Dana-Farber Cancer Insitute at Londonderry Hospital, Londonderry
- Solinsky Center for Cancer Care (NH Oncology-Hematology, PA), Manchester
- a 1 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 19. 8. 2026 · NCT04893109MRg-NIRS Imaging System Breast Cancer Trial
- Dartmouth-Hitchcock Medical Center, Lebanon
Prebieha nábor
Vek 18 až 83 · Ženy · Aktualizované 23. 6. 2026 · NCT06400563A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
- Dartmouth-Hitchcock Clinic, Lebanon
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 6. 2026 · NCT06258993STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)
- Dartmouth-Hitchcock Medical Center, Lebanon
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 5. 5. 2026 · NCT05716516De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Prebieha náborFáza 3
Vek 50 až 70 · Všetky pohlavia · Aktualizované 23. 4. 2026 · NCT04852887Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
- Dartmouth Cancer Center/Dartmouth-Hitchcock Medical Center, Lebanon
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 2. 2026 · NCT02926690Evaluating the Use of a Medication 'Switch' vs Guideline-directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients
- Dartmouth Cancer Center, Lebanon
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 12. 2. 2026 · NCT07071038Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
- Dartmouth Cancer Center, Lebanon
Prebieha náborFáza 1
Vek 18 a viac · Ženy · Aktualizované 20. 11. 2025 · NCT05900895Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.